Novel FOXM1 Inhibitors to Assist Cancer Treatment

Search text
Active Filters
Life Science Research Tool
About 6 results
(0.07 seconds)
What differentiates this technology is its specialized focus on Pin1 overexpression, making it a unique tool for understanding cell cycle regulation in cancer biology.
The technology involves a genetically engineered MCF-7 breast cancer cell line that has been modified to overexpress the Pin1 protein, a key peptidyl-prolyl cis/trans isomerase important for cell cycle regulation.
This cell model facilitates detailed investigations into the cellular mechanisms governing breast cancer progression and provides a platform for screening compounds that might affect cell cycle dynamics.
A novel cell line has been developed by using AAV gene targeting to effectively delete a segment of the FADD genomic locus in HCT116 colon cancer cells obtained from ATCC.
Its unparalleled capability to completely disrupt FADD function provides an innovative platform to explore therapeutic resistance in cancer treatments, making it a valuable resource for both basic research and drug development applications.
Its unparalleled capability to completely disrupt FADD function provides an innovative platform to explore therapeutic resistance in cancer treatments, making it a valuable resource for both basic research and drug development applications. Applications. - Cancer drug screening platform. - Therapeutic resistance testing model.
- Facilitates in-depth investigations into BID and FADD mediated processes in colon cancer cells.
This technology involves a series of modified HCT116 colon cancer cell lines in which the BID gene has been completely deleted from both chromosomes using AAV gene targeting.
Two extensively characterized clones display these unique features, making them an exceptional model for studying apoptosis pathways and the interplay between intrinsic and extrinsic cell death mechanisms in cancer research.
    • Technology Type
      • 17
        Therapeutic Modality
      • 6
        Life Science Research Tool
      • 1
        Diagnostic/Assay
      • Add ...
    • Technology Subtype
      • 3
        Cell Line
      • 1
        Protein
      • Add ...
    • Therapeutic Areas
      • 6
        Oncology
      • Add ...
    • Therapeutic Indications
      • 3
        Colorectal cancer
      • 1
        Breast cancer
      • Add ...
    • Tags
      • Add ...
    • Lead Inventor
      • 3
        Jian Yu
      • 1
        Chuanyue Wu
      • 1
        Lin Zhang
      • 1
        Shivendra Singh
      • Add ...
    • Department
      • 4
        Med-Pathology
      • 2
        Med-Pharmacology and Chemical Biology
      • Add ...
    • All Tech Innovators
      • 4
        Jian Yu
      • 4
        Lin Zhang
      • 1
        Chuanyue Wu
      • 1
        Shivendra V. Singh
      • Add ...
    • Date Submitted
This site uses cookies to deliver a better user experience. Learn more.